Docoh
Loading...

IFF International Flavors & Fragrances

IFF uses Uncommon Sense to create what the world needs. As a collective of unconventional thinkers and creators, the Company puts science and artistry to work to create unique and unexpected scents, tastes, experiences and ingredients for the products its world craves.

Company profile

Ticker
IFF, IFFT
Exchange
Website
CEO
Andreas Fibig
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
131432060

IFF stock data

(
)

Calendar

10 May 21
14 Jun 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
28 May 21 Jilla Rustom Stock Equivalent Unit Common Stock Grant Aquire A No No 141.67 23.823 3.38K 544.56
28 May 21 Robert G. Anderson Stock Equivalent Unit Common Stock Grant Aquire A No No 141.67 9.651 1.37K 5,579.772
28 May 21 Andreas Fibig Stock Equivalent Unit Common Stock Grant Aquire A No No 141.67 81.248 11.51K 62,880.675
14 May 21 Gordon Ilene S Common Stock Buy Aquire P No No 140.3857 1,000 140.39K 1,255
14 May 21 Andreas Fibig Stock Equivalent Unit Common Stock Grant Aquire A No No 141.21 81.513 11.51K 62,799.427

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

91.2% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 720 44 +1536.4%
Opened positions 685 7 +9685.7%
Closed positions 9 11 -18.2%
Increased positions 23 11 +109.1%
Reduced positions 10 12 -16.7%
13F shares
Current Prev Q Change
Total value 31.71B 1.46B +2077.7%
Total shares 227.07M 22.93M +890.1%
Total puts 968.6K 0 NEW
Total calls 590.9K 0 NEW
Total put/call ratio 1.6
Largest owners
Shares Value Change
Vanguard 27.54M $3.84B NEW
Winder Investment Pte 24.13M $3.37B +715.6%
BLK Blackrock 19.29M $2.69B +1251.5%
STT State Street 10.31M $1.45B +2985.0%
TROW T. Rowe Price 7.77M $1.08B NEW
Sachem Head Capital Management 6.51M $908.78M NEW
Capital International Investors 6.05M $845.17M NEW
Alliancebernstein 5.32M $742.87M -30.5%
EdgePoint Investment 5.27M $735.3M NEW
Nuveen Asset Management 5.25M $732.87M NEW
Largest transactions
Shares Bought/sold Change
Vanguard 27.54M +27.54M NEW
Winder Investment Pte 24.13M +21.17M +715.6%
BLK Blackrock 19.29M +17.86M +1251.5%
STT State Street 10.31M +9.98M +2985.0%
TROW T. Rowe Price 7.77M +7.77M NEW
Sachem Head Capital Management 6.51M +6.51M NEW
Capital International Investors 6.05M +6.05M NEW
EdgePoint Investment 5.27M +5.27M NEW
Nuveen Asset Management 5.25M +5.25M NEW
Barrow Hanley Mewhinney & Strauss 4.9M +4.9M NEW

Financial report summary

?
Competition
GivaudanSymrise
Management Discussion
  • Cost of goods sold includes the cost of materials and manufacturing expenses. R&D includes expenses related to the development of new and improved products and technical product support. S&A expenses include expenses necessary to support our commercial activities and administrative expenses supporting our overall operating activities including compliance with governmental regulations.
  • Sales for the first quarter of 2021 increased $1.118 billion, or 83% on a reported basis, to $2.465 billion, compared to $1.347 billion in the prior year quarter. Performance was primarily driven by $1.076 billion of incremental sales that was attributable to the inclusion of N&B, which was merged and consolidated into our results of operations effective February 1, 2021. In addition, sales performance reflected growth for the Nourish, Health & Biosciences and Scent segments, primarily driven by volume increases across the three segments.
  • (1)Currency neutral sales growth is calculated by translating current year invoiced sale amounts at the exchange rates for the corresponding prior year period.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: abide, accomplished, accuracy, activist, affirmative, aim, analyzing, animal, appellate, arrive, attrition, automatically, bakery, biofuel, Black, Borg, brand, brewing, calendar, canceled, carbohydrate, cheese, Circuit, commodity, comparison, composed, confectionery, convenience, converted, covenant, culinary, deductible, dietary, dishwashing, dismissed, divest, divestiture, division, dosage, drug, effort, elderly, enable, enabling, enacted, enzyme, ethanol, EVENT, extension, farm, feed, fermentation, fermented, fewer, fiber, finite, fractional, fresh, Frulact, gas, Grain, hair, hardware, high, hold, hypothetical, indenture, infant, label, largest, laundry, leasehold, lieu, life, low, machinery, maintenance, meal, microbial, multiplied, Nourish, obsolescence, oil, oral, pea, pharma, pharmaceutical, proceeding, protein, PSU, quotient, realignment, reassigned, release, relevant, relief, remeasured, renewal, royalty, RSA, RSU, SAR, satisfaction, seasoning, serve, shelf, slightly, solution, soybean, stability, sugar, surety, sweet, textile, transparency, treasury, treatment, Trust, twenty, unadjusted, undiscounted, unvested, variety, vested, visibility, Vision, waste, whichever, xi, yogurt
Removed: accrual, adequate, advantage, Africa, announced, Antitrust, approval, aroma, arrange, arrangement, Asia, Asian, bond, borrowed, borrower, botanical, bridge, broader, Canada, capitalizing, caption, closely, cloud, collectively, commitment, competitive, complexity, comprising, computing, conduct, consolidate, consummated, consummation, contact, continuity, contracting, contractual, creating, creative, criteria, decline, declined, deep, delayed, deliver, dependent, difficult, directly, drawn, duration, earlier, East, economy, eliminate, entity, environment, evolving, experienced, expiration, expired, external, face, fail, FDA, fee, finalization, finest, fish, footprint, Force, geographically, governing, grouping, guaranteed, heighten, heightened, hosting, human, immaterial, impacted, impacting, implementation, imposed, imposing, improvement, increasing, incur, India, innovator, insight, integral, intimacy, investee, Latin, leader, letter, license, light, limit, lived, LLC, logistical, mandated, manifested, merge, methodology, Middle, minimal, mitigation, monitoring, Morgan, move, negatively, obtaining, outbreak, partially, people, performed, personnel, powder, presently, preserve, preventative, priced, priority, producing, productivity, promise, proposed, protective, provision, rapidly, reallocated, recall, recognition, recommending, recurring, region, reinstated, relaxed, remotely, requirement, Resolving, retrospective, sanitization, select, sensory, shipment, shipping, situation, solidified, sourced, Specifically, spread, Stanley, stocking, strictest, subjected, Subtopic, successful, Suisse, supportable, syndicate, Task, temperature, temporarily, terminated, testing, transport, turn, uncollectable, upgrading, visitor, waiting, week, workforce

Patents

APP
Utility
Novel Dienoates and Their Use In Perfume Compositions
3 Jun 21
The present invention relates to a novel compound and its use as a fragrance material.
GRANT
Utility
Preparing unsaturated carbocyclic compounds
1 Jun 21
Disclosed are methods of preparing unsaturated carbocyclic compounds through dehydrogenation of corresponding saturated carbocyclic compounds.
APP
Utility
Powder Composition for Cosmetic and Health Use
20 May 21
A passenger cabin monitoring system includes infrared cameras disposed in respective passenger rest compartments, a flight attendant information system including at least one display and at least one speaker, and a computing device in communication with the infrared cameras and the flight attendant, information system.
GRANT
Utility
Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucoside
18 May 21
Recombinant microorganisms, plants, and plant cells are disclosed that have been engineered to express a mutant AROM polypeptide and/or mutant catechol-O-methyltransferase polypeptide alone or in combination with one or more vanillin biosynthetic enzymes or UDP-glycosyltransferases (UGTs).
GRANT
Utility
Stereoselective synthesis of perhydro-3,6-dialkyl-2-benzo[b]furanones and analogs
4 May 21
Synthetic methods of preparing perhydro-3,6-dimethyl-2-benzo[b]furanones, in particular dihydromintlactone, and analogs through reaction of dehydrogenation of menthanediols and analogs with a base in the presence of (carbonylchlorohydrido[bis-(2-diphenylphosphinoethyl)amine]ruthenium(II) as catalyst in good stereoselectivity and yields under stereochemistry controlled conditions are disclosed.